Sponsor Pipeline

Shanghai BDgene Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
5
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1
2
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06474442 A Phase Ⅱa Study of the Safety, Tolerability and Efficacy of BD111 in Herpes Simplex… Herpes Simplex Virus Type I Stromal Keratitis Recruiting
Phase 1
NCT06465550 A Phase 1 Study of Gene-modified Autologous Hematopoietic Stem Cell (BD211) Treating… β-thalassemia Recruiting
NCT06474416 A Study of the Safety, Tolerability and Prelinminary Efficacy of BD111 in Herpes Simplex… Herpes Simplex Virus Type I Stromal Keratitis Active, Not Recruiting
Not specified
NCT05773729 Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat… β-thalassemia Recruiting
NCT05776173 Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat… β-thalassemia Major Recruiting
NCT07170254 A Clinical Study on the Evaluation of BD114 for the Treatment HPV-16-Related Cervical HSIL High-grade Squamous Intraepithelial Lesions (HSIL) Recruiting
Disease Areas
Get alerts when Shanghai BDgene Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free